Telemus Capital’s Northwest Biotherapeutics NWBO Stock Holding History
Bought
Maintained
Sold
Other funds holding NWBO
CDH
BW
Telemus Capital's NWBO Position: Q4 2016 in Review
Telemus Capital sold out of Northwest Biotherapeutics (NWBO) in Q4 2016, closing a stake of 32,401 shares — an estimated $18K sold.
Telemus Capital first reported a position in NWBO in Q2 2016 and held it in 2 quarters. The position peaked at $18K in Q3 2016. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.
- Telemus Capital reported no remaining Northwest Biotherapeutics position as of Q4 2016 after selling out during the quarter.
- Telemus Capital sold 32,401 Northwest Biotherapeutics shares in Q4 2016, an estimated $18K.
- Telemus Capital first reported a position in Northwest Biotherapeutics in Q2 2016 and held it in 2 quarters.
- Telemus Capital's Northwest Biotherapeutics position peaked at $18K in Q3 2016.
- 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2016.
Based on Telemus Capital's 13F filing for Q4 2016, filed 24 Jan 2017.